Italia markets close in 8 minutes

BMY Aug 2025 30.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,10000,0000 (0,00%)
In data: 12:07PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,1000
Aperto1,2200
Denaro0,7500
Domanda2,5600
Prezzo d'esercizio30,00
Scadenza2025-08-15
Min-Max giorno1,1000 - 1,2200
Contratto - Min-MaxN/D
Volume30
Open Interest60
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri